Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$12.00 – $19.34
10% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.48B | $6.08B | $6.83B | $8.75B | $9.34B | $8.14B | $8.93B | $9.65B |
| Cost of revenue | $918.2M | $995.3M | $1.12B | $5.33B | $1.60B | $1.28B | $1.45B | $6.46B |
| Gross profit | $4.56B | $5.19B | $5.71B | $3.43B | $7.74B | $6.87B | $7.48B | $3.19B |
| Gross margin | 83.2% | 85.4% | 83.6% | 39.1% | 82.8% | 84.3% | 83.8% | 33.1% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $695.4M | $699.9M | $811.9M | $3.18B | $3.52B | $2.63B | $2.69B | $2.92B |
| EBITDA | $951.5M | $1.08B | $1.42B | $2.56B | $2.83B | $1.28B | $1.66B | $1.24B |
| Net income | $475.6M | $549.7M | $527.7M | $1.32B | $1.46B | $685.0M | $511.1M | $513.6M |
| Net margin | 8.7% | 9.0% | 7.7% | 15.0% | 15.6% | 8.4% | 5.7% | 5.3% |
| EPS (diluted) | 1.12 | 1.22 | 1.11 | 2.73 | 3.02 | 1.45 | 1.07 | 1.07 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $11.0B | $1.23 | $1.17–$1.27 | 1 |
| 2027 | $11.3B | $1.30 | $1.25–$1.35 | 1 |
| 2028 | $11.8B | $1.41 | $1.35–$1.46 | 1 |
| 2029 | $12.3B | $1.53 | $1.46–$1.59 | 1 |
Forward consensus · source: Financial Modeling Prep
SONIC HEALTHCARE LTD
No one on the platform currently holds SKHCF.
No tracked institution reports a position in SKHCF as of their last filing.
No one on the platform has traded SKHCF yet.
| $5.5B |
| — |
| KYKOFKyowa Kirin Co., Ltd. | $14.20 | -1.59% | $7.4B | — |
| MSMKFMatsukiyoCocokara & Co. | $14.60 | +0.00% | $5.7B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 3.6× earnings vs its 14.7× historical median P/E.
Fair value ≈ $51.76 · price $12.76 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.